REPORT ID 2824

Global RNAi for Therapeutic Market Professional Survey Report 2017

Publish Date
11-Dec-17
Pages
116
Format
Electronic (PDF)

This report studies RNAi for Therapeutic in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
    Alnylam Pharmaceuticals
    Arbutus Biopharma (Tekmira)
    Arrowhead Research
    Dicerna Pharmaceuticals
    Mirna Therapeutics
    Quark Pharmaceuticals
    RXi Pharmaceuticals
    Silence Therapeutics
    Benitec Biopharma
    Miragen Therapeutics
    Sylentis
    Gradalis
    Sirnaomics
    Silenseed
    Arcturus Therapeutics
    Ariz Biopharma
    Celsion Corporation
    Ascletis Pharmaceuticals

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    siRNA
    miRNA
    shRNA

By Application, the market can be split into
    Cancer
    Cardiovascular
    HBV
    Other

By Regions, this report covers (we can add the regions/countries as you want)
    North America
    China
    Europe
    Southeast Asia
    Japan
    India

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global RNAi for Therapeutic Market Professional Survey Report 2017
1 Industry Overview of RNAi for Therapeutic
    1.1 Definition and Specifications of RNAi for Therapeutic
        1.1.1 Definition of RNAi for Therapeutic
        1.1.2 Specifications of RNAi for Therapeutic
    1.2 Classification of RNAi for Therapeutic
        1.2.1 siRNA
        1.2.2 miRNA
        1.2.3 shRNA
    1.3 Applications of RNAi for Therapeutic
        1.3.1 Cancer
        1.3.2 Cardiovascular
        1.3.3 HBV
        1.3.4 Other
    1.4 Market Segment by Regions
        1.4.1 North America
        1.4.2 China
        1.4.3 Europe
        1.4.4 Southeast Asia
        1.4.5 Japan
        1.4.6 India

2 Manufacturing Cost Structure Analysis of RNAi for Therapeutic
    2.1 Raw Material and Suppliers
    2.2 Manufacturing Cost Structure Analysis of RNAi for Therapeutic
    2.3 Manufacturing Process Analysis of RNAi for Therapeutic
    2.4 Industry Chain Structure of RNAi for Therapeutic

3 Technical Data and Manufacturing Plants Analysis of RNAi for Therapeutic
    3.1 Capacity and Commercial Production Date of Global RNAi for Therapeutic Major Manufacturers in 2016
    3.2 Manufacturing Plants Distribution of Global RNAi for Therapeutic Major Manufacturers in 2016
    3.3 R&D Status and Technology Source of Global RNAi for Therapeutic Major Manufacturers in 2016
    3.4 Raw Materials Sources Analysis of Global RNAi for Therapeutic Major Manufacturers in 2016

4 Global RNAi for Therapeutic Overall Market Overview
    4.1 2012-2017E Overall Market Analysis
    4.2 Capacity Analysis
        4.2.1 2012-2017E Global RNAi for Therapeutic Capacity and Growth Rate Analysis
        4.2.2 2016 RNAi for Therapeutic Capacity Analysis (Company Segment)
    4.3 Sales Analysis
        4.3.1 2012-2017E Global RNAi for Therapeutic Sales and Growth Rate Analysis
        4.3.2 2016 RNAi for Therapeutic Sales Analysis (Company Segment)
    4.4 Sales Price Analysis
        4.4.1 2012-2017E Global RNAi for Therapeutic Sales Price
        4.4.2 2016 RNAi for Therapeutic Sales Price Analysis (Company Segment)

5 RNAi for Therapeutic Regional Market Analysis
    5.1 North America RNAi for Therapeutic Market Analysis
        5.1.1 North America RNAi for Therapeutic Market Overview
        5.1.2 North America 2012-2017E RNAi for Therapeutic Local Supply, Import, Export, Local Consumption Analysis
        5.1.3 North America 2012-2017E RNAi for Therapeutic Sales Price Analysis
        5.1.4 North America 2016 RNAi for Therapeutic Market Share Analysis
    5.2 China RNAi for Therapeutic Market Analysis
        5.2.1 China RNAi for Therapeutic Market Overview
        5.2.2 China 2012-2017E RNAi for Therapeutic Local Supply, Import, Export, Local Consumption Analysis
        5.2.3 China 2012-2017E RNAi for Therapeutic Sales Price Analysis
        5.2.4 China 2016 RNAi for Therapeutic Market Share Analysis
    5.3 Europe RNAi for Therapeutic Market Analysis
        5.3.1 Europe RNAi for Therapeutic Market Overview
        5.3.2 Europe 2012-2017E RNAi for Therapeutic Local Supply, Import, Export, Local Consumption Analysis
        5.3.3 Europe 2012-2017E RNAi for Therapeutic Sales Price Analysis
        5.3.4 Europe 2016 RNAi for Therapeutic Market Share Analysis
    5.4 Southeast Asia RNAi for Therapeutic Market Analysis
        5.4.1 Southeast Asia RNAi for Therapeutic Market Overview
        5.4.2 Southeast Asia 2012-2017E RNAi for Therapeutic Local Supply, Import, Export, Local Consumption Analysis
        5.4.3 Southeast Asia 2012-2017E RNAi for Therapeutic Sales Price Analysis
        5.4.4 Southeast Asia 2016 RNAi for Therapeutic Market Share Analysis
    5.5 Japan RNAi for Therapeutic Market Analysis
        5.5.1 Japan RNAi for Therapeutic Market Overview
        5.5.2 Japan 2012-2017E RNAi for Therapeutic Local Supply, Import, Export, Local Consumption Analysis
        5.5.3 Japan 2012-2017E RNAi for Therapeutic Sales Price Analysis
        5.5.4 Japan 2016 RNAi for Therapeutic Market Share Analysis
    5.6 India RNAi for Therapeutic Market Analysis
        5.6.1 India RNAi for Therapeutic Market Overview
        5.6.2 India 2012-2017E RNAi for Therapeutic Local Supply, Import, Export, Local Consumption Analysis
        5.6.3 India 2012-2017E RNAi for Therapeutic Sales Price Analysis
        5.6.4 India 2016 RNAi for Therapeutic Market Share Analysis

6 Global 2012-2017E RNAi for Therapeutic Segment Market Analysis (by Type)
    6.1 Global 2012-2017E RNAi for Therapeutic Sales by Type
    6.2 Different Types of RNAi for Therapeutic Product Interview Price Analysis
    6.3 Different Types of RNAi for Therapeutic Product Driving Factors Analysis
        6.3.1 siRNA of RNAi for Therapeutic Growth Driving Factor Analysis
        6.3.2 miRNA of RNAi for Therapeutic Growth Driving Factor Analysis
        6.3.3 shRNA of RNAi for Therapeutic Growth Driving Factor Analysis

7 Global 2012-2017E RNAi for Therapeutic Segment Market Analysis (by Application)
    7.1 Global 2012-2017E RNAi for Therapeutic Consumption by Application
    7.2 Different Application of RNAi for Therapeutic Product Interview Price Analysis
    7.3 Different Application of RNAi for Therapeutic Product Driving Factors Analysis
        7.3.1 Cancer of RNAi for Therapeutic Growth Driving Factor Analysis
        7.3.2 Cardiovascular of RNAi for Therapeutic Growth Driving Factor Analysis
        7.3.3 HBV of RNAi for Therapeutic Growth Driving Factor Analysis
        7.3.4 Other of RNAi for Therapeutic Growth Driving Factor Analysis

8 Major Manufacturers Analysis of RNAi for Therapeutic
    8.1 Alnylam Pharmaceuticals
        8.1.1 Company Profile
        8.1.2 Product Picture and Specifications
            8.1.2.1 Product A
            8.1.2.2 Product B
        8.1.3 Alnylam Pharmaceuticals 2016 RNAi for Therapeutic Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.1.4 Alnylam Pharmaceuticals 2016 RNAi for Therapeutic Business Region Distribution Analysis
    8.2 Arbutus Biopharma (Tekmira)
        8.2.1 Company Profile
        8.2.2 Product Picture and Specifications
            8.2.2.1 Product A
            8.2.2.2 Product B
        8.2.3 Arbutus Biopharma (Tekmira) 2016 RNAi for Therapeutic Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.2.4 Arbutus Biopharma (Tekmira) 2016 RNAi for Therapeutic Business Region Distribution Analysis
    8.3 Arrowhead Research
        8.3.1 Company Profile
        8.3.2 Product Picture and Specifications
            8.3.2.1 Product A
            8.3.2.2 Product B
        8.3.3 Arrowhead Research 2016 RNAi for Therapeutic Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.3.4 Arrowhead Research 2016 RNAi for Therapeutic Business Region Distribution Analysis
    8.4 Dicerna Pharmaceuticals
        8.4.1 Company Profile
        8.4.2 Product Picture and Specifications
            8.4.2.1 Product A
            8.4.2.2 Product B
        8.4.3 Dicerna Pharmaceuticals 2016 RNAi for Therapeutic Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.4.4 Dicerna Pharmaceuticals 2016 RNAi for Therapeutic Business Region Distribution Analysis
    8.5 Mirna Therapeutics
        8.5.1 Company Profile
        8.5.2 Product Picture and Specifications
            8.5.2.1 Product A
            8.5.2.2 Product B
        8.5.3 Mirna Therapeutics 2016 RNAi for Therapeutic Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.5.4 Mirna Therapeutics 2016 RNAi for Therapeutic Business Region Distribution Analysis
    8.6 Quark Pharmaceuticals
        8.6.1 Company Profile
        8.6.2 Product Picture and Specifications
            8.6.2.1 Product A
            8.6.2.2 Product B
        8.6.3 Quark Pharmaceuticals 2016 RNAi for Therapeutic Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.6.4 Quark Pharmaceuticals 2016 RNAi for Therapeutic Business Region Distribution Analysis
    8.7 RXi Pharmaceuticals
        8.7.1 Company Profile
        8.7.2 Product Picture and Specifications
            8.7.2.1 Product A
            8.7.2.2 Product B
        8.7.3 RXi Pharmaceuticals 2016 RNAi for Therapeutic Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.7.4 RXi Pharmaceuticals 2016 RNAi for Therapeutic Business Region Distribution Analysis
    8.8 Silence Therapeutics
        8.8.1 Company Profile
        8.8.2 Product Picture and Specifications
            8.8.2.1 Product A
            8.8.2.2 Product B
        8.8.3 Silence Therapeutics 2016 RNAi for Therapeutic Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.8.4 Silence Therapeutics 2016 RNAi for Therapeutic Business Region Distribution Analysis
    8.9 Benitec Biopharma
        8.9.1 Company Profile
        8.9.2 Product Picture and Specifications
            8.9.2.1 Product A
            8.9.2.2 Product B
        8.9.3 Benitec Biopharma 2016 RNAi for Therapeutic Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.9.4 Benitec Biopharma 2016 RNAi for Therapeutic Business Region Distribution Analysis
    8.10 Miragen Therapeutics
        8.10.1 Company Profile
        8.10.2 Product Picture and Specifications
            8.10.2.1 Product A
            8.10.2.2 Product B
        8.10.3 Miragen Therapeutics 2016 RNAi for Therapeutic Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.10.4 Miragen Therapeutics 2016 RNAi for Therapeutic Business Region Distribution Analysis
    8.11 Sylentis
    8.12 Gradalis
    8.13 Sirnaomics
    8.14 Silenseed
    8.15 Arcturus Therapeutics
    8.16 Ariz Biopharma
    8.17 Celsion Corporation
    8.18 Ascletis Pharmaceuticals

9 Development Trend of Analysis of RNAi for Therapeutic Market
    9.1 Global RNAi for Therapeutic Market Trend Analysis
        9.1.1 Global 2017-2022 RNAi for Therapeutic Market Size (Volume and Value) Forecast
        9.1.2 Global 2017-2022 RNAi for Therapeutic Sales Price Forecast
    9.2 RNAi for Therapeutic Regional Market Trend
        9.2.1 North America 2017-2022 RNAi for Therapeutic Consumption Forecast
        9.2.2 China 2017-2022 RNAi for Therapeutic Consumption Forecast
        9.2.3 Europe 2017-2022 RNAi for Therapeutic Consumption Forecast
        9.2.4 Southeast Asia 2017-2022 RNAi for Therapeutic Consumption Forecast
        9.2.5 Japan 2017-2022 RNAi for Therapeutic Consumption Forecast
        9.2.6 India 2017-2022 RNAi for Therapeutic Consumption Forecast
    9.3 RNAi for Therapeutic Market Trend (Product Type)
    9.4 RNAi for Therapeutic Market Trend (Application)

10 RNAi for Therapeutic Marketing Type Analysis
    10.1 RNAi for Therapeutic Regional Marketing Type Analysis
    10.2 RNAi for Therapeutic International Trade Type Analysis
    10.3 Traders or Distributors with Contact Information of RNAi for Therapeutic by Region
    10.4 RNAi for Therapeutic Supply Chain Analysis

11 Consumers Analysis of RNAi for Therapeutic
    11.1 Consumer 1 Analysis
    11.2 Consumer 2 Analysis
    11.3 Consumer 3 Analysis
    11.4 Consumer 4 Analysis

12 Conclusion of the Global RNAi for Therapeutic Market Professional Survey Report 2017
    Methodology
    Analyst Introduction
    Data Source